Education
About Us
Working with TipRanks
Follow Us
Oncodesign Precision Medicine S.A. (FR:ALOPM)
:ALOPM
ALOPM Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.28 - €1.38
Previous CloseN/A
Volume28.87K
Average Volume (3M)7.42K
Market Cap
€5.53M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.45
Next Earnings
Sep 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.40
Shares Outstanding18,190,878
10 Day Avg. Volume7,334
30 Day Avg. Volume7,421
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ALOPM FAQ
What was Oncodesign Precision Medicine S.A.’s price range in the past 12 months?
Oncodesign Precision Medicine S.A. lowest stock price was €0.28 and its highest was €1.38 in the past 12 months.
What is Oncodesign Precision Medicine S.A.’s market cap?
Oncodesign Precision Medicine S.A.’s market cap is €5.53M.
When is Oncodesign Precision Medicine S.A.’s upcoming earnings report date?
Oncodesign Precision Medicine S.A.’s upcoming earnings report date is Sep 23, 2025 which is in 88 days.
How were Oncodesign Precision Medicine S.A.’s earnings last quarter?
Oncodesign Precision Medicine S.A. released its earnings results on Apr 03, 2025. The company reported -€0.196 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.196.
Is Oncodesign Precision Medicine S.A. overvalued?
According to Wall Street analysts Oncodesign Precision Medicine S.A.’s price is currently Overvalued.
Does Oncodesign Precision Medicine S.A. pay dividends?
Oncodesign Precision Medicine S.A. does not currently pay dividends.
What is Oncodesign Precision Medicine S.A.’s EPS estimate?
Oncodesign Precision Medicine S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncodesign Precision Medicine S.A. have?
Oncodesign Precision Medicine S.A. has 18,190,878 shares outstanding.
What happened to Oncodesign Precision Medicine S.A.’s price movement after its last earnings report?
Oncodesign Precision Medicine S.A. reported an EPS of -€0.196 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Oncodesign Precision Medicine S.A.?
Currently, no hedge funds are holding shares in FR:ALOPM
Technical Analysis
Quantum Genomics
―
Hybrigenics SA Class A
―
TME Pharma N.V.
―
Biophytis SA
―
Theranexus SA
―